Hematology Analyzers

Sysmex Corporation is a global clinical laboratory diagnostics manufacturer specializing in hematology, hemostasis, urinalysis, flow cytometry, and laboratory informatics solutions. The company designs and manufactures fully automated and compact hematology analyzers, hemostasis testing systems, and urinalysis instruments for clinical laboratory environments ranging from high-volume reference labs to low-volume hospital labs. Sysmex's product portfolio includes the CN-6000 hemostasis analyzer for specialty testing and the UN-Series urinalysis systems. The company provides automated complete blood count (CBC) analyzers that perform approximately 400 million tests annually across 12,000+ clinical laboratories worldwide. Sysmex offers trusted reagents for routine and specialty testing, integrated laboratory information systems, and comprehensive service and support programs. The company has achieved 90% auto-validation rates in CBC testing and ranked #1 in hematology analyzer reliability, system performance, and service support for over 20 years according to independent IMV ServiceTrak surveys. Sysmex holds 2024 IMV ServiceTrak Awards for Best Customer Satisfaction, Best System Performance, and Best Service in hematology. The company serves hospital labs, reference laboratories, and clinical diagnostic centers with regulatory compliance and quality assurance across all product lines.

DIESSE Diagnostica Senese S.p.A. is an Italian manufacturer of in vitro diagnostic (IVD) systems headquartered in Siena, specializing in immunochemistry, infectious disease diagnostics, autoimmune testing, and automated erythrocyte sedimentation rate (ESR) measurement. Founded in the 1980s, the company operates as a research-focused Società Benefit with over 180 employees and exports to more than 100 countries. DIESSE manufactures a comprehensive portfolio of automated and manual diagnostic solutions including the CHORUS EVO platform for immunochemistry, VES-MATIC 5 for ESR analysis with AI integration, AUTO-DAT for standardized seroagglutination testing, Enzywell for manual immunochemistry, and iRapid for rapid immunodiagnostics. All products are produced in-house in Italy, emphasizing quality, sustainability, and ethical practices. The company serves clinical laboratories, hematology centers, and infectious disease diagnostics facilities globally.

CMB Lab (Consolidated Medical Bio-Analysis, Inc.) is a full-service CLIA and CAP accredited clinical laboratory established in 1979, providing comprehensive diagnostic services to physicians, hospitals, and pharmaceutical companies. The laboratory offers routine blood analyses, HIV testing, anatomic pathology, and advanced genomic testing. CMB specializes in clinical assays and custom assay development for the pharmaceutical and biotechnology sectors, including biomarker testing and validation across Phase I–IV clinical trials. The company operates multiple patient service centers with courier service and maintains a provider web portal for results management. CMB combines clinical laboratory services with dedicated clinical trials and research capabilities, focusing on early disease detection, diagnosis optimization, and therapeutic monitoring.

Onyvia Biolabs (formerly Prove Clinical Laboratories) is a state-of-the-art central laboratory in Sydney's CBD specialising in comprehensive clinical trial services for pharmaceutical companies, biotechs, and CROs. ISO/IEC 17025 accredited by NATA, the laboratory supports Phase I–III trials across multiple therapeutic areas with 6–8 week study startup timelines. Core capabilities include bioanalytical testing via LC-MS/MS and HPLC platforms for pharmacokinetic (PK) analysis, automated ELISA for biomarker testing, safety testing (biochemistry, haematology, coagulation, serology), histopathology with immunohistochemistry and digital imaging, flow cytometry, and PBMC isolation and storage. Additional services encompass kit assembly, sample storage across ambient and ultra-low temperature conditions (-80°C, liquid nitrogen), project management, LIMS database development, international sample logistics, site training, and vendor management. The laboratory is equipped with high-throughput, fully automated analysers and employs a team of PhD-level scientists and clinical pathologists.

SST International Inc. (Scientific Supplies & Technology Int'l) is a Miami-based medical and laboratory equipment distributor serving healthcare facilities, clinical laboratories, research institutions, and water testing facilities across the Caribbean, Central, and South America since 1977. The company provides access to thousands of diagnostic and laboratory products from over 150 trusted manufacturers, including hematology analyzers, immunoassay systems, PCR equipment, microbiology analyzers, and comprehensive laboratory consumables (pipettes, specimen containers, reagents, blood collection tubes). SST offers factory-trained field service engineers located across the Americas for rapid equipment service and support, specializing in point-of-care testing systems, laboratory automation solutions, and chemistry analyzers. The company serves hospitals, clinics, private and public clinical laboratories, industry quality control labs, water testing laboratories, and research institutions with reagents, consumables, chemicals, furnishings, and equipment.

NuWav Labs is a CLIA-certified, COLA-accredited clinical laboratory offering comprehensive diagnostic solutions including core laboratory testing (chemistry, hematology, immunology), molecular diagnostics (COVID-19, Flu A/B, RSV), and high-quality reagents and kits for healthcare providers and diagnostic laboratories. The company specializes in fast turnaround times with 99% accuracy across 500+ test types, operating under HIPAA compliance and federal regulatory standards. NuWav serves as a scalable diagnostic partner for hospitals, clinics, and research institutions requiring reliable laboratory testing and reagent supply.

ARUP Laboratories is a national, academic, nonprofit reference laboratory established in 1984 as part of the University of Utah's Department of Pathology. Operating 65 highly automated laboratory facilities with 4,300 employees, ARUP serves healthcare providers nationwide with over 3,000 diagnostic tests. The laboratory maintains a two-story freezer capable of storing 2.3 million specimens and provides industry-leading turnaround times. ARUP's test menu encompasses genetics, molecular oncology, pediatrics, neurology, hematopathology, and infectious disease testing. Beyond core laboratory services, ARUP offers comprehensive consulting through its Healthcare Advisory Services division, addressing laboratory stewardship, operations optimization, outreach planning, and data analytics. The company maintains a robust research and innovation program through its Institute for Research and Innovation in Diagnostic and Precision Medicine, supporting clinical trials, pharmaceutical companion diagnostics, and academic research initiatives. ARUP provides ARUP Consult®, a clinical decision support resource featuring testing algorithms and expert insights, alongside continuing education for laboratory professionals. CAP-, CLIA-, and ISO 15189-accredited, ARUP serves academic medical centers, children's hospitals, government facilities, and healthcare systems across the U.S.

Lab Warehouse, Inc. is a clinical laboratory supplier and distributor headquartered in Puerto Rico, established in 1993. The company specializes in hematology, chemistry, urinalysis, and coagulation instruments; rapid diagnostic tests for infectious diseases, pregnancy, and drug screening; laboratory reagents and consumables; and specimen handling equipment including microscopes, centrifuges, and mixers. Lab Warehouse also develops and markets BestLab.net, a comprehensive laboratory information and management system (LIMS) designed for full clinical laboratory automation with compliance to CLIA, HIPAA, and local regulations. The system provides patient data management, quality control programs, electronic billing, workflow analysis, and decision-support analytics for laboratory administrators. The company serves clinical laboratories, physician offices, and veterinary laboratories across Puerto Rico, with expansion into the U.S., Central America, South America, and the Caribbean.

Plymouth Medical is a Brooklyn-based orthobiologics and regenerative medicine company specializing in evidence-based products and services for healthcare providers across orthopedics, sports medicine, pain management, dermatology, plastics, regenerative esthetics, urology, and OBGYN. The company offers a comprehensive portfolio including platelet-rich plasma (PRP) systems, microfat grafting devices, analgesia systems, hemocytometers, wireless ultrasound probes, and microneedling devices. Beyond product distribution, Plymouth Medical provides clinical staff training, quality control services through PRP analysis and characterization (PAC), patient outcome tracking via the DataBiologics registry, and post-treatment rehabilitation support through digital remote therapeutic monitoring platforms. The company operates with a small core team supported by independent sales representatives across North America, emphasizing ethical guidelines and evidence-based practice in regenerative and orthobiologic treatments.

QIAGEN is a multinational life sciences company specializing in sample preparation, nucleic acid purification, and molecular diagnostic technologies. The company offers comprehensive solutions including consumable kits for DNA/RNA extraction, automation systems for sample processing, and advanced diagnostic platforms utilizing PCR, digital PCR (dPCR), and next-generation sequencing (NGS). QIAGEN serves diverse markets including clinical laboratories, pharmaceutical and biotech companies, academic research institutions, and organizations in forensics, food safety, and pathogen surveillance. The company provides integrated solutions spanning discovery and translational research, diagnostics and clinical research, human ID and forensics applications, and informatics and data analysis. With over 500,000 customers globally, QIAGEN delivers end-to-end workflows under its "Sample to Insight" philosophy, combining instruments, consumables, and software platforms for molecular testing and biomarker discovery.

Carolina Liquid Chemistries Corp. manufactures and distributes clinical laboratory analyzers and reagents for physician offices, hospitals, and reference laboratories of all sizes. The company's core product portfolio includes the CLC Family of fully automated benchtop and high-volume chemistry analyzers (DZ-Lite c270, CLC800, CLC1600, CLC6410), offering throughputs from 270 to 1,600 tests/hour with integrated ion-selective electrode (ISE) capabilities. CLC markets Tosoh immunoassay analyzers (AIA-360, AIA-900, AIA-2000) and the G8 HPLC analyzer for HbA1c testing, as well as Mindray hematology analyzers (BC-3600, BC-5390). The company supplies a comprehensive reagent line covering 40 general chemistries, 27 urine drug screening assays, 15 immunochemistry tests, and 24 special chemistries including Lp-PLA2, Vitamin D, Procalcitonin, and Human Kappa/Lambda Free Light Chains. CLC offers refurbished Olympus AU and BioLIS 24i/CLC480 chemistry analyzers as cost-effective solutions. The company serves small, rural, and critical access hospitals, providing support for CLIA-regulated testing and maintaining compliance with Clinical Laboratory Improvement Amendments. CLC holds CLIA moderate-complexity categorization for its ethyl alcohol assay and maintains focus on reducing cost, space, and turnaround times for clinical laboratories. The company targets federal buyers including Veterans Affairs (VA) and Department of Defense (DoD) customers. CLC reports over 95% customer satisfaction year-over-year and provides comprehensive service and support infrastructure.

Quest Diagnostics is a large-scale clinical laboratory services provider operating 2,000+ patient service centers across the United States. The company performs over 200 million laboratory tests annually across all patient demographics. Quest offers a comprehensive portfolio of 3,500+ laboratory tests including cardiology markers (Lp(a), ApoB, LDL-C), hematology, biochemistry, genetic testing, prenatal diagnostics (noninvasive prenatal testing, maternal serum screening), and oncology screening. The company serves patients, healthcare professionals, health plans, hospitals, health systems, employers, and life sciences/biopharma organizations. Quest operates significant laboratory automation infrastructure with ongoing modernization efforts and provides IT solutions including Quanum Lab Services Manager for healthcare professionals and healthcare systems. The company recently launched Quest AI Companion, a patient-facing digital tool within MyQuest that provides simplified explanations of lab results. Quest Diagnostics operates a B2B laboratory network model serving as a reference laboratory for hospitals and health systems, providing billing and coding support, and offering population health and workforce health solutions. The organization adheres to clinical laboratory standards and regulatory requirements for laboratory-developed tests.

Guangzhou Wondfo Biotech Co., Ltd. is a leading in vitro diagnostics (IVD) manufacturer headquartered in Guangzhou, China, founded in 1992. The company employs over 3,000 staff and operates 20+ subsidiaries across 150+ countries. Wondfo specializes in point-of-care testing (POCT) and clinical laboratory diagnostics across eight major technology platforms: Colloidal Gold (rapid diagnostic tests for infectious disease, fertility, drugs-of-abuse); Immunofluorescence (50+ assay reagents and 7 high-performance analyzers for cardiovascular, inflammatory, renal, endocrine, and oncology biomarkers); Chemiluminescence (single-dose immunoassay analyzers with maintenance-free design); Coagulation (optical and semi-automatic blood coagulation analyzers for PT, APTT, TT, FIB, ACT); Blood Gas (portable BGA-102 analyzer delivering results in 30 seconds); Molecular Diagnostics (RT-PCR reagents and platforms for infectious disease including COVID-19); Pathology (PA-3600 automated immunohistochemical staining system); and HPLC Hemoglobin (Truth-H80E analyzer for HbA1c measurement within 60-90 seconds for diabetes diagnosis and monitoring). Products are distributed through clinical laboratories, hospitals, point-of-care settings, emergency departments, and ICUs globally. The Finecare Meter series holds the largest installed base in Chinese medical institutions. Wondfo holds WHO prequalification for select infectious disease products and maintains CE and regulatory compliance across major markets. The company supports healthcare systems with integrated POCT lab solutions and participates actively in international clinical laboratory and diagnostics conferences.

Drew Scientific manufactures and sells analytical instruments and reagents for clinical and veterinary hematology applications worldwide. The company specializes in automated cell counters for human clinical hematology, veterinary hematology, and research use, as well as hemoglobin analyzers for diabetes monitoring (HbA1c). Product lines include the Hematology D3 and D5 systems for clinical use, and the Vet Hematology 950 and 950LV systems for veterinary and research applications. Drew Scientific also supplies reagents and controls to support these instruments. The company operates from their facility in Plantation, Florida, with dedicated customer service and technical support teams. Distribution capabilities include direct sales to healthcare facilities and veterinary practices, as well as distributor channels. Operating hours are Monday–Friday, 9:00 AM to 5:00 PM EST, with appointment-only weekend availability.

Integrated Diagnostics Group (IDG), a division of Sanzay Corporation, is a Miami Gardens-based laboratory diagnostics manufacturer and consolidated distributor serving Latin American and North American markets. IDG designs, manufactures, and distributes clinical laboratory reagents, controls, calibrators, and diagnostic test kits across multiple therapeutic and analytical domains. Product lines include chemistry and immunoassay reagents, calibrators and controls, CLIA/ELISA assays, point-of-care diagnostics, hematology and coagulation reagents, rapid diagnostic tests, serology assays, and urine diagnostic strips. IDG operates as an OEM manufacturer and contract manufacturer, offering bulk supply, private label manufacturing, and consolidated distribution services. The company provides quality assurance services (IDGQAS), laboratory consulting, and integrated sourcing solutions. IDG serves clinical laboratories, hospital laboratory departments, point-of-care testing sites, and diagnostic distributors across Latin America. The company emphasizes efficiency, reliability, and accuracy in product design and manufacturing. Services include sub-manufacturing programs, custom formulation, and consolidated procurement management.

Boule Diagnostics AB is a global provider of diagnostic solutions specializing in hematology analyzers and clinical chemistry systems for decentralized human and veterinary laboratory markets. The company manufactures high-quality hematology and clinical chemistry analyzers alongside associated reagents, controls, and calibrators designed to enhance access to timely and accurate blood test results globally. Through its CDS subsidiary, Boule develops and manufactures custom reagents, controls, and calibrators tailored to partner specifications, serving OEM customers worldwide. The company operates across multiple countries with a distributed network of partners, laboratory systems, and test capacity exceeding millions of tests annually, with significant presence in rural and underserved healthcare areas. Boule's product portfolio is engineered for the decentralized laboratory segment, including point-of-care and smaller clinical laboratory settings in both human and veterinary healthcare sectors.

Werfen is a global in vitro diagnostics company operating directly in over 30 countries and through distributors in more than 100 territories. The company develops, manufactures, and commercializes diagnostic systems, reagents, software, and services across hemostasis, acute care diagnostics, transfusion, autoimmunity, transplant, immunoassay, and clinical chemistry. Werfen's hemostasis portfolio includes in vitro diagnostic systems and reagents for diagnosing and guiding treatment of thrombotic and bleeding disorders. The acute care diagnostics line provides integrated whole-blood testing solutions for cardiovascular operating rooms, catheterization laboratories, intensive care units, and emergency departments. The transfusion division offers manual and automated solutions with serology reagents, fully automated instrumentation, data management software, and molecular products for donor-recipient compatibility. The autoimmunity segment delivers reagents and lab automation for diagnosing and monitoring autoimmune diseases. Transplant products feature molecular and antibody-based HLA assays and software for pretransplant compatibility determination and post-transplant monitoring. Clinical chemistry solutions serve chemistry and pharma-toxicology laboratories. Werfen also recently completed the acquisition of Omixon, a Budapest-based company specializing in next-generation sequencing technologies for transplant diagnostics. The company maintains a technology center in Bedford, Massachusetts, expanded in December 2024. Werfen's solutions are designed to improve patient care quality, reduce laboratory costs, ensure regulatory compliance, and enhance operational efficiency across clinical laboratory and acute care hospital settings.

Infitek is a professional manufacturer of laboratory and medical equipment based in Shanghai, China, established in 2010. The company specializes in scientific instruments and medical devices for pharmaceutical, biopharmaceutical, and clinical laboratory applications. With 18 manufacturing facilities and certifications including ISO 9001 and ISO 13485, Infitek serves over 176 countries globally. The company's product portfolio encompasses incubators, refrigeration equipment, centrifuges, spectrophotometers, autoclaves, gas chromatographs, real-time PCR systems, hematology analyzers, and comprehensive sample preparation and analysis equipment. Infitek provides integrated solutions for pharmaceutical workflows, clinical diagnostics, and laboratory automation, complemented by purchasing and inspection services in China and comprehensive after-sales support.

Diamond Diagnostics Inc. is a specialized clinical laboratory instrumentation and consumables supplier based in Holliston, Massachusetts, founded in 1996. The company manufactures, remanufactures, and supplies new and refurbished chemistry analyzers, electrolyte analyzers, immunoassay systems, blood gas analyzers, coagulation analyzers, hematology analyzers, and molecular analyzers. With approximately 80 employees and ~$19M annual revenue, Diamond offers over 500 consumable products including reagents, quality controls, and electrodes. The company's proprietary Down-To-Frame® refurbishment process restores equipment to like-new condition. Most products hold FDA clearance and CE approval. Diamond provides comprehensive field service, depot service, preventive maintenance, remote support, control assay, and refurbishment services to clinical laboratories and hospitals globally. ISO 9001:2015 and ISO 13485:2016 certified, the company also offers OEM and contract manufacturing for third-party organizations.

HORIBA is a multinational group providing analytical and diagnostic instruments, systems, and solutions across multiple sectors. In healthcare, HORIBA specializes in in vitro diagnostic systems including hematology analyzers (Yumizen H-series), which support clinical laboratory diagnostics for various user types: patients, physicians, private laboratories, clinics, and university hospitals. The company manufactures blood analyzers, hematology systems, and related laboratory instrumentation with demonstrated clinical utility in disease detection and monitoring. Beyond healthcare, HORIBA operates across automotive R&D (mobility), environmental and process monitoring, semiconductor manufacturing metrology, scientific instruments, and life science applications. The organization offers optical spectroscopy solutions (including custom-configured spectrometers, monochromators, and CCD systems), OEM spectroscopy and imaging components (gratings, spectrometers, cameras from VUV to NIR), and particle size analyzers. HORIBA maintains a global footprint with multiple subsidiaries and operations worldwide. The company demonstrates commitment to quality and regulatory compliance in clinical diagnostics, evidenced by product development workshops and clinical case studies supporting transfusion safety and diagnostic accuracy.

Acro Biotech, Inc. is a medical diagnostics manufacturer based in Montclair, California, specializing in point-of-care and clinical laboratory testing solutions. The company develops and distributes a diverse portfolio of diagnostic analyzers and rapid testing systems across multiple therapeutic and clinical domains. Product lines include respiratory infection rapid tests (COVID-19 and other respiratory panels, though COVID tests are not FDA-cleared for US distribution), drugs of abuse screening tests, cardiac biomarker assays, urine analyzers, fluorescence immunoassay analyzers, and multiparameter handheld meters for hemoglobin, cholesterol, uric acid, and glucose testing. The company also offers solutions for women's health, infectious disease serology, tumor markers, and veterinary diagnostics. Key analyzer platforms include the ATR-ACO300 urine analyzer, AFR-600 fluorescence immunoassay system (Apoti), AHR-100 multiparameter meter for hemoglobin/cholesterol/uric acid/glucose, and LF Reader systems. The company serves clinical laboratories, point-of-care testing facilities, and veterinary markets with rapid testing and automated laboratory equipment. No specific FDA 510(k) clearances, ISO certifications, or CE Mark designations are stated on the website. Manufacturing capabilities and regulatory status for products marketed outside the US are not detailed in available content.

Since 1986, Jant Pharmacal Corporation has been a leading B2B supplier of point-of-care (POC) diagnostic tests and laboratory instrumentation to U.S. and international healthcare settings. The company operates two primary divisions: POC Division and Lab Division. The POC Division offers CLIA-waived rapid tests and analyzers for use in physicians' offices, clinics, urgent care centers, and hospitals under registered trademarks Accutest, Accustrip, and LipidPlus. Product categories include cardiac testing, colorectal cancer screening, drugs of abuse, hypothyroidism, infectious diseases, pregnancy & fertility, and urinalysis. The Lab Division provides integrated solutions for laboratory optimization, featuring clinical chemistry, hematology, immunoassay, toxicology, urinalysis, and molecular diagnostic systems with reagents and consumables. The company holds GPO supplier contracts with Vizient and Champs, representing over 500,000 members. Additionally, Jant offers laboratory consultation services including financial feasibility assessment, turn-key laboratory setup, CLIA compliance consultation, LCMS method development, and laboratory information system integration.

Isla Lab Products, LLC is a Puerto Rico–based medical laboratory distributor and supplier founded in 1977 and expanded to the Caribbean in 2007. Headquartered at Amelia Industrial Park in Guaynabo, PR, the company operates a 30,000-square-foot facility with sales, customer service, technical and professional support, cold chain distribution, conference facilities, and a training center. The company distributes and supplies a comprehensive portfolio of clinical laboratory analyzers, reagents, consumables, and diagnostics across multiple specialties: clinical chemistry, immunochemistry, microbiology, hematology, transfusion medicine and blood banking, point-of-care testing, molecular diagnostics, pathology, toxicology, coagulation studies, COVID-19 testing, and rapid diagnostics. Key product offerings include automated chemistry analyzers (cobas® c 513, cobas® pure), microbiology identification and blood culture systems (VITEK® 2, BACT/ALERT® VIRTUO®, BACT/ALERT® 3D), rapid antigen testing platforms (Quidel Sofia 2), blood collection tubes (Vacuette®), and hematology analyzers (BC-5390). The company serves clinical laboratories, hospitals, diagnostic centers, and healthcare institutions across Puerto Rico and the Caribbean islands. Isla Lab Products maintains technical service capabilities, professional training, and cold chain logistics to support customer operations. The company operates as an authorized distributor for major in vitro diagnostics manufacturers and provides B2B procurement solutions for laboratory testing infrastructure and consumables.

Beckman Coulter Diagnostics is a global leader in clinical diagnostics and biomedical testing, headquartered in Brea, California. A subsidiary of Danaher Corporation since its foundational 1935 establishment, the company develops, manufactures, and distributes innovative laboratory automation systems, analyzers, and informatics solutions for clinical and research laboratories worldwide. The company specializes in clinical chemistry systems, immunoassay instruments, hematology analyzers, urinalysis systems, microbiology solutions, blood banking instruments, and protein chemistry platforms. Beckman Coulter also provides total lab automation systems (DxA 5000 series), advanced informatics middleware (Remisol Advance), and remote diagnostic services. Its comprehensive portfolio supports healthcare professionals and laboratory teams in disease diagnosis, treatment decisions, patient monitoring, and improved health outcomes. With annual revenue of approximately $2.9 billion, the company emphasizes efficiency, automation, clinical confidence, and integrated workflow solutions for hospital laboratories, reference laboratories, and blood banks globally.

High Technology, Inc. (HTI) manufactures laboratory analyzers engineered specifically for emerging healthcare systems and resource-constrained environments. The company specializes in clinical diagnostic equipment including hematology, clinical chemistry, electrolyte, urinalysis, and coagulation analyzers. HTI's core value proposition centers on delivering reliable diagnostic performance in real-world conditions—fluctuating power supply, varying ambient temperatures, and challenging infrastructure—without requiring ideal laboratory conditions. Products feature intuitive touchscreen interfaces with multilingual support, role-based access controls, and are designed for operation across diverse skill levels. HTI operates a distributor-partnership model, offering exclusive territorial agreements, factory training and certification programs, protected distribution channels, and regional support teams across Africa, Latin America, Asia, and Eastern Europe. The company also manufactures veterinary diagnostic analyzers using the same robust, real-world-focused engineering principles. Products mentioned include the HTI MicroCC-25 Plus, a 5-part hematology analyzer designed for community outpatient labs, rural clinics, district hospitals, and maternal health programs. HTI emphasizes consistent reagent supply chains, data protection, and sustainable local partnerships rather than treating distributors as replaceable sales channels. The organization positions itself as a healthcare infrastructure builder serving mid-market and emerging-economy clinical settings.

Diatron U.S. Inc, a member of the STRATEC group, is a manufacturer of in vitro diagnostic (IVD) analyzers and reagents for clinical laboratory use. The company specializes in hematology analyzers, clinical chemistry analyzers, and immunoassay systems. Product lines include the Aquila, Aquarius 3, Abacus 5, Abacus 380, and Abacus Junior 30 hematology analyzers for human clinical diagnostics, along with the Abacus Vet5 for veterinary applications. Clinical chemistry offerings include the Pictus 500 (P500), Pictus 700, and P780 fully automated analyzers. Immunoassay capabilities include the GEMINI ELISA system and KleeYa chemiluminescent analyzer. Diatron also manufactures hematology reagents, controls, calibrators, and clinical chemistry reagents to support its analyzer platforms. The company serves clinical laboratories, hospital laboratory departments, and reference laboratories globally. Manufacturing capabilities include reagent development, quality control testing, and technical support services. The company maintains quality management systems and operates a distributor network for market reach and customer support.

Germaine Laboratories, Inc. is an FDA-registered manufacturer and distributor of in vitro diagnostic tests and reagents serving medical, drug testing, veterinary, and food & beverage industries since 1990. The company holds ISO 13485:2016 certification for quality management systems applicable to diagnostic test manufacturing. Product portfolio includes urinalysis reagent strips (AimStrip®), hemoglobin testing systems (AimStrip® Hemoglobin), strep detection tests (StrepAim®), pregnancy tests (AimStep®), blood glucose monitoring systems (VQPet H for veterinary use), COVID-19 antigen home tests (Flowflex™), and reducing substance tablets for food testing (AimTab™). The company serves physician offices, walk-in clinics, pharmacies, hospitals, drug court programs, schools, workplaces, veterinary practices, and food & beverage manufacturers. All products are CLIA-waived where applicable and FDA-approved. Germaine Laboratories operates as both a manufacturer and distributor, offering bulk packaging, private labeling, OEM arrangements, and exclusive distributorship opportunities. The company provides laboratory services and tableting contract manufacturing capabilities. Customer service and technical support are available 24/7 via phone and email, with emphasis on rapid response and order fulfillment.